2
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Anticoagulants: A Guide for Practitioners

First of Two Parts

, MD, PhD
Pages 88-92 | Published online: 06 Jul 2016

REFERENCES

  • Davie EW, Hougie C, Lundblad RL: Mechanisms of Blood Coagulation. In Poller L (Editor): Recent Advances in Blood Coagulation. London, J & A Churchill Ltd, 1969, p 13
  • Ratnoff OD, Davie EW: The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI). Biochemistry 1: 677, 1962
  • Pitlick FA, Lundblad RL, Davie EW: The role of heparin in intrinsic blood coagulation. J Biomed Mater Res 3: 95, 1969
  • Salafsky B, Loomis TA: The effect of heparin, heparinoids, and other electro-negative compounds on the in vitro thrombin-fibrinogen conversion and on whole blood-clotting time. Arch Int Pharmacodyn Ther 150: 107, 1964
  • Rodriguez-Erdmann F: Bleeding due to increased intravascular blood coagulation: Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). N Engl J Med 273: 1370, 1965
  • Goldfine ID, Schachter H, Barclay WR, et al: Consumption coagulopathy in miliary tuberculosis. Ann Intern Med 71: 775, 1969
  • Corrigan JJ Jr, Jordan CM: Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med 283: 778, 1970
  • Jorpes E: Heparin. London, Oxford University Press Inc, 1946
  • Bauer G: Heparin therapy in acute deep venous thrombosis. JAMA 131: 196, 1946
  • Bauer G: Nine years' experience with heparin in acute venous thrombosis. Angiology 1: 161, 1950
  • Bauer G: Thirteen years' experience of heparin therapy. In Thrombosis and Embolism, First International Conference, Basel, 1954, p 721
  • Jorpes JE: Heparin, its chemistry, pharmacology and clinical use. Am J Med 33: 692, 1962
  • Morris LE, Balk P: The management and mismanagement of acute venous thrombosis (thrombophlebitis) of the extremities. Angiology 16: 339, 1965
  • Deykin D, Salzman EW, Mayer R: Prospective study of complications of heparin therapy. (Abstr) III Congress, The International Society on Thrombosis and Haemostasis, Washington, DC, 1972, p 416
  • Douglas AS: Current Status, of Anticoagulant Treatment. In Poller (Editor),1 p 107
  • Hattersley PG: Activated coagulation time of whole blood. JAMA 196: 436, 1966
  • Wessler S, Deykin D: Theory and practice in acute venous thrombosis. Circulation 18: 1190, 1958
  • Urokinase Pulmonary Embolism Trial Study Group: Urokinase pulmonary embolism trial. Phase I results. JAMA 213: 2163, 1970
  • Millikan CH, Siekert RG, Whisnant JP (Editors): Cerebral Vascular Diseases. New York, Grune and Stratton Inc, 1965
  • Marshall J, Reynolds EH: Withdrawal of anticoagulants from patients with transient ischemic cerebrovascular attacks. Lancet 1: 5, 1965
  • Whisnant JP, Matsumoto N, Elvebeck LR: The prognosis and treatment of transient ischemic attacks in a community. Neurology 22: 441, 1972
  • Carter AB: Anticoagulant treatment in progressing stroke. Br Med J 5244: 70, 1961
  • Brown TR, Poskanzer DC: Treatment of strokes. N Engl J Med 281: 594, 650, 1969

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.